TY  - JOUR
AU  - Udell, Jacob A
AU  - Petrie, Mark C
AU  - Jones, W Schuyler
AU  - Anker, Stefan D
AU  - Harrington, Josephine
AU  - Mattheus, Michaela
AU  - Seide, Svenja
AU  - Amir, Offer
AU  - Bahit, M Cecilia
AU  - Bauersachs, Johann
AU  - Bayes-Genis, Antoni
AU  - Chen, Yundai
AU  - Chopra, Vijay K
AU  - Figtree, Gemma
AU  - Ge, Junbo
AU  - Goodman, Shaun G
AU  - Gotcheva, Nina
AU  - Goto, Shinya
AU  - Gasior, Tomasz
AU  - Jamal, Waheed
AU  - Januzzi, James L
AU  - Jeong, Myung Ho
AU  - Lopatin, Yuri
AU  - Lopes, Renato D
AU  - Merkely, Béla
AU  - Martinez-Traba, Monica
AU  - Parikh, Puja B
AU  - Parkhomenko, Alexander
AU  - Ponikowski, Piotr
AU  - Rosselló, Xavier
AU  - Schou, Morten
AU  - Simic, Dragan
AU  - Steg, Philippe Gabriel
AU  - Szachniewicz, Joanna
AU  - van der Meer, Peter
AU  - Vinereanu, Dragos
AU  - Zieroth, Shelley
AU  - Brueckmann, Martina
AU  - Sumin, Mikhail
AU  - Bhatt, Deepak L
AU  - Hernandez, Adrian F
AU  - Butler, Javed
PY  - 2024
DO  - 10.1016/j.jacc.2024.03.405
UR  - https://hdl.handle.net/20.500.13003/20330
T2  - Journal of the American College of Cardiology
AB  - Empagliflozin reduces the risk of heart failure (HF) hospitalizations but not all-cause mortality when started within 14 days of acute myocardial infarction (AMI).This study sought to evaluate the association of left ventricular ejection fraction...
LA  - eng
PB  - Elsevier
KW  - acute myocardial infarction
KW  - congestion
KW  - empagliflozin
KW  - heart failure
KW  - left ventricular dysfunction
KW  - Aged
KW  - Benzhydryl Compounds* / therapeutic use
KW  - Double-Blind Method
KW  - Female
KW  - Follow-Up Studies
KW  - Glucosides* / therapeutic use
KW  - Heart Failure* / drug therapy
KW  - Heart Failure* / mortality
KW  - Hospitalization / statistics & numerical data
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Myocardial Infarction* / drug therapy
KW  - Myocardial Infarction* / epidemiology
KW  - Sodium-Glucose Transporter 2 Inhibitors* / therapeutic use
KW  - Stroke Volume / drug effects
KW  - Ventricular Function, Left* / drug effects
TI  - Left Ventricular Function, Congestion, and Effect of Empagliflozin on Heart Failure Risk After Myocardial Infarction
TY  - research article
ER  -